Skip to content
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
Search
Day: September 13, 2024

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

September 13, 2024

AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.

Read More

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

September 13, 2024

AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.

Read More

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

September 13, 2024

AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.

Read More

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

September 13, 2024

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

September 13, 2024

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

September 13, 2024

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More
Page1 Page2 Page3 Page4 Page5
RECENT POSTS

Ebola Outbreak in Eastern DR Congo Claims Over 300 Children; New Vaccine Trials Recommended

August 7, 2026

DR Congo Ebola Outbreak Surpasses 4,000 Cases Amidst Expanding Health Response

August 7, 2026

Ebola Cases Surpass 4,000 in Democratic Republic of Congo

August 7, 2026

Antwerp Confronts Colonial Past with Monument to Human Zoo Victims

August 7, 2026

Ebola Death Toll Tops 1,800 in DRC

August 7, 2026

DRCs Largest Ebola Outbreak on Record: Active Conflict and Armed Groups Hamper the Response

August 7, 2026

Nigeria Slashes Malaria Burden To 15 Pct Over 15 Years

August 6, 2026

At Least 308 Kidnapped Victims Rescued In Nigerian Military Operation

August 6, 2026
Copyright © 2026 Le Congo Tribune. All Rights Reserved.